Hi-Tech sales down due to cough-cold recalls
AMITYVILLE, N.Y. Early indications of the industrywide voluntary recall of children’s cough-cold medicines marketed for infants under the age of 2 are negative as it pertains to retail sales, as another cough-cold distributor pointed to the recall as a significant factor behind a companywide decline in sales.
For the three months ended Oct. 31, Hi-Tech Pharmacal reported net sales of $15.9 million, a decrease of 2 percent as compared with the same period last year. Sales for the healthcare products division, which markets the company’s OTC branded products, decreased 38 percent to $2.3 million, largely due to the discontinuation of the children’s formula of Diabetic Tussin at certain retailers.
“We believe the balance of the year will show growth as our core diabetic products continue to do well, and we prepare to introduce several exciting new products in the balance of the fiscal year,” stated Hi-Tech president and chief executive officer David Seltzer.
Last month, Prestige Brands reported its second-quarter results were negatively impacted in part by the voluntary removal of two kids cough-cold products under the Little Remedies banner.
FDA approves Confidant mobile phone system for OTC sales
RESEARCH TRIANGLE PARK, N.C. The Food and Drug Administration has given Confidant market clearance for the over-the-counter sale of its chronic disease management product. Confidant is a manufacturer of mobile communication solutions for chronic disease management.
In May 2005, Confidant became the first company to receive clearance from the FDA for a mobile phone-based system to communicate with multiple home medical devices. This was followed by the October 2006 clearance, which included significant user interface improvements and the ability to work with a broader group of home medical devices.
Initially, the focus was on home diabetes management, with the system being capable of collecting data from a range of glucose meters, weight scales and blood pressure devices. With the OTC product, users can collect data from the same full range of off-the-shelf devices supported by the company’s prescription product. Objective and motivational feedback is returned directly to the user’s cell phone within seconds and automatic reminders help the user keep on track with routine monitoring.
Patient data can be accessed directly through the Confidant portal or by accessing Personal Health Record or Electronic Medical Record systems that are populated from the Confidant system.
Gerolymatos announces Breathe Again is top seller in U.S.
NEW YORK Earlier this year, Gerolymatos introduced its European nasal saline spray, Breathe Again with Sinomarin, to the United States, where it has become a top seller, the company announced in a press release Monday. According to Information Resources data as provided by Gerolymatos, Breathe Again was the leading saline nasal spray in the drug stores for the month of October.
Breathe Again with SinoMarin nasal spray is harvested from pure tidal seawater off France’s Atlantic coast, and then filtered and mixed with purified water in a ratio that closely mirrors the body’s interstitial fluid. It is an all natural hypertonic saline solution that helps to clean, clear and moisturize nasal passages.
Breathe Again is now available at Wal-Mart, Walgreens, Rite Aid and other major drug and supermarket retailers in both adult and pediatric formulas. The suggested retail price is $9.99.